PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CWK vs. NMRK
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CWK and NMRK is 0.68, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.7

Performance

CWK vs. NMRK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cushman & Wakefield plc (CWK) and Newmark Group, Inc. (NMRK). The values are adjusted to include any dividend payments, if applicable.

0.00%10.00%20.00%30.00%40.00%AugustSeptemberOctoberNovemberDecember2025
3.31%
11.70%
CWK
NMRK

Key characteristics

Sharpe Ratio

CWK:

0.50

NMRK:

0.61

Sortino Ratio

CWK:

1.02

NMRK:

1.07

Omega Ratio

CWK:

1.12

NMRK:

1.13

Calmar Ratio

CWK:

0.34

NMRK:

0.45

Martin Ratio

CWK:

2.07

NMRK:

2.65

Ulcer Index

CWK:

9.77%

NMRK:

8.09%

Daily Std Dev

CWK:

40.51%

NMRK:

35.24%

Max Drawdown

CWK:

-71.84%

NMRK:

-83.84%

Current Drawdown

CWK:

-47.28%

NMRK:

-31.20%

Fundamentals

Market Cap

CWK:

$2.80B

NMRK:

$3.00B

EPS

CWK:

$0.38

NMRK:

$0.30

PE Ratio

CWK:

32.08

NMRK:

41.33

Total Revenue (TTM)

CWK:

$6.82B

NMRK:

$1.87B

Gross Profit (TTM)

CWK:

$1.17B

NMRK:

$1.87B

EBITDA (TTM)

CWK:

$294.00M

NMRK:

$188.59M

Returns By Period

In the year-to-date period, CWK achieves a -6.80% return, which is significantly lower than NMRK's -3.20% return.


CWK

YTD

-6.80%

1M

-19.43%

6M

3.31%

1Y

21.05%

5Y*

-8.79%

10Y*

N/A

NMRK

YTD

-3.20%

1M

-16.67%

6M

11.70%

1Y

25.25%

5Y*

2.03%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CWK vs. NMRK — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CWK
The Risk-Adjusted Performance Rank of CWK is 6464
Overall Rank
The Sharpe Ratio Rank of CWK is 6767
Sharpe Ratio Rank
The Sortino Ratio Rank of CWK is 6262
Sortino Ratio Rank
The Omega Ratio Rank of CWK is 6060
Omega Ratio Rank
The Calmar Ratio Rank of CWK is 6464
Calmar Ratio Rank
The Martin Ratio Rank of CWK is 6969
Martin Ratio Rank

NMRK
The Risk-Adjusted Performance Rank of NMRK is 6767
Overall Rank
The Sharpe Ratio Rank of NMRK is 7070
Sharpe Ratio Rank
The Sortino Ratio Rank of NMRK is 6464
Sortino Ratio Rank
The Omega Ratio Rank of NMRK is 6161
Omega Ratio Rank
The Calmar Ratio Rank of NMRK is 6868
Calmar Ratio Rank
The Martin Ratio Rank of NMRK is 7373
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CWK vs. NMRK - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Cushman & Wakefield plc (CWK) and Newmark Group, Inc. (NMRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for CWK, currently valued at 0.50, compared to the broader market-4.00-2.000.002.000.500.61
The chart of Sortino ratio for CWK, currently valued at 1.02, compared to the broader market-4.00-2.000.002.004.001.021.07
The chart of Omega ratio for CWK, currently valued at 1.12, compared to the broader market0.501.001.502.001.121.13
The chart of Calmar ratio for CWK, currently valued at 0.34, compared to the broader market0.002.004.006.000.340.45
The chart of Martin ratio for CWK, currently valued at 2.07, compared to the broader market-10.000.0010.0020.002.072.65
CWK
NMRK

The current CWK Sharpe Ratio is 0.50, which is comparable to the NMRK Sharpe Ratio of 0.61. The chart below compares the historical Sharpe Ratios of CWK and NMRK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.00AugustSeptemberOctoberNovemberDecember2025
0.50
0.61
CWK
NMRK

Dividends

CWK vs. NMRK - Dividend Comparison

CWK has not paid dividends to shareholders, while NMRK's dividend yield for the trailing twelve months is around 0.97%.


TTM2024202320222021202020192018
CWK
Cushman & Wakefield plc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NMRK
Newmark Group, Inc.
0.97%0.94%1.09%1.25%0.21%1.78%2.90%3.37%

Drawdowns

CWK vs. NMRK - Drawdown Comparison

The maximum CWK drawdown since its inception was -71.84%, smaller than the maximum NMRK drawdown of -83.84%. Use the drawdown chart below to compare losses from any high point for CWK and NMRK. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%AugustSeptemberOctoberNovemberDecember2025
-47.28%
-31.20%
CWK
NMRK

Volatility

CWK vs. NMRK - Volatility Comparison

Cushman & Wakefield plc (CWK) has a higher volatility of 11.92% compared to Newmark Group, Inc. (NMRK) at 10.40%. This indicates that CWK's price experiences larger fluctuations and is considered to be riskier than NMRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


6.00%8.00%10.00%12.00%14.00%16.00%18.00%AugustSeptemberOctoberNovemberDecember2025
11.92%
10.40%
CWK
NMRK

Financials

CWK vs. NMRK - Financials Comparison

This section allows you to compare key financial metrics between Cushman & Wakefield plc and Newmark Group, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab